Here are relevant reports on : rare-earth-element-market
-
Rare Earth Industry Challenges and Outlook 2011-2020
Rare Earth elements (REE) are 17 different rare earth elements which are used extensively in a wide variety of applications to make technologies lighter, stronger, more efficient, and easier to use. REEs are used to make super strong permanent magnets that increase the efficiency of wind generators while significantly reducing their weight. They are used extensively in electric vehicles to increase battery capacity and reduce weight, in medicine for small, portable X-ray devices as well as lasers that can treat glaucoma and other conditions. The United States produced most of the world’s REE up until about 1985, at which time China began to become a major supplier. Today, China produces about 97% of the world’s rare earths. Problems stemming from this (virtually) single source include supply constraints, reduced shipments and export quotas, environmental problems, and rising prices. There is huge worry from many industry players of potential supply crunch of REE from China.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Rare Earth Metals Market by Type (Lanthanum Oxide, Cerium Oxide, Neodymium Oxide, Europium Oxide, Terbium Oxide), Application (Permanent Magnets, Catalysts, Glass Polishing, Phosphors, Metal Alloys, Ceramics), and Region - Global Forecast to 2030
The market for rare earth metals is projected to reach USD 7,386.3 million by 2030, at a CAGR of 6.2%. The rare earth metals market comprises major players, such as Lynas Rare Earths Ltd. (Australia), Australian Strategic Materials Ltd. (Australia), Arafura Rare Earths Limited (Australia), Shenghe Resources Holding Co. Ltd (China), China Rare Earth Holdings Limited (China), Baotou HEFA Rare Earth Co. Ltd. (China), Canada Rare Earth Corporation (Canada), Northern Minerals (Australia), MP Materials (US), Avalon Advanced Materials Inc. (Canada), and others, which are covered in the rare earth metals market. Expansions, acquisitions, joint ventures, and product developments are some of the major strategies adopted by these key players to enhance their positions in the rare earth metals market.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Inorganic Scintillators Market by Scintillation Material (NaI, CsI, LSO & LYSO), Type (Alkali Halides, Rare Earth Metals), & Application (Healthcare, Homeland Security & Defense, Nuclear Power Plants) - Analysis - Global Forecast to 2021
The inorganic scintillators market size is projected to grow at a CAGR of 5.2%. Growing safety concerns post the Fukushima disaster, growing security threats, growing security budgets of global sporting events, increasing incidence of cancer, growth in the number of PET/CT scans, and growing threat of nuclear terrorism are expected to drive the growth of the market in the coming years.
- Published: October 2016
- Price: $ 4950
- TOC Available:
-
Rare Earth Magnets Market by Type (NdFeB, SmCo), Manufacturing Process (Sintered, Bonded), End-use Industry (Automotive, Consumer Electronics, Aerospace & Defense, Energy, Industrial, Other End-use Industries), and Region - Global Forecast to 2030
The rare earth magnets market is expected to grow from USD 21.98 billion in 2025 to USD 30.01 billion by 2030, at a CAGR of 6.4% during the forecast period. The rare earth magnets market comprises major players such as Proterial, Ltd. (Japan), Shin-Etsu Chemical Co., Ltd. (Japan), TDK Corporation (Japan), and VACUUMSCHMELZE (Germany). Partnerships, collaborations, and expansions are some of the major strategies adopted by these key players to enhance their positions in the rare earth magnets market.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Rare Earth Metals Recycling Market by Application (Permanent Magnets, Alloys, Polishing Materials, Glass, Catalyst, Phosphor, Ceramics, Hydrogen Storage Alloys), Technology (Hydrometallurgical, Pyrometallurgical) and Region - Global Forecasts to 2026
The global rare earth metals recycling market is estimated to be USD 248 million in 2021 and is projected to reach USD 422 million by 2026, at a CAGR of 11.2% from 2021 to 2026. The demand for these elements is likely to rise over the forecast period due to their sustained demand in are key components in emerging applications, including metal alloys, catalysts, permanent magnets, phosphors, polishing, and glass additives.
- Published: March 2022
- Price: $ 4950
- TOC Available:
-
RNA Therapeutics Market by Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), Indication (Infectious Diseases, Rare Genetic Diseases), End User (Hospitals & Clinics) & Region - Global Forecast to 2028
The global RNA therapeutics market, valued at US$32.2 billion in 2022, stood at US$13.7 billion in 2023 and is projected to advance at a resilient CAGR of 5.6% from 2023 to 2028, culminating in a forecasted valuation of US$18.0 billion by the end of the period. Growth in this market is largely driven by factors such as the increasing number of partnerships and collaborations among market players and RNA technology manufacturers, expanding modalities for RNA therapeutics, and the rising number of emergency use authorizations and approvals for COVID-19 booster vaccines.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020
The NGS services market in Europe is expected to reach USD 1,152 Million by 2020 from USD 444 Million in 2015, at a CAGR of 21% from 2015 to 2020. Factors such as rising preference of NGS over other platforms; rapid and cost-efficient sequencing; rising prevalence of inherited diseases; application of genomics in drug discovery; growing prevalence of cancer and other malignant diseases; and partnerships among companies, R&D centers, and universities are expected to drive market growth. However, high dependence on grants for R&D, lack of analytics, and stringent reimbursement policies are likely to restrict the growth of this market to a certain extent.
- Published: October 2015
- Price: $ 4950
- TOC Available:
-
mRNA Therapeutics Market by Product (Vaccines, Drugs), Application (Oncology, Rare Diseases, Infectious Diseases, Other Applications), End User (Hospitals & Clinics, Research Settings) - Global Forecast to 2027
The global mRNA therapeutics market is projected to reach USD ~35 billion by 2027 from USD 32 billion in 2022, at a CAGR of ~2% between 2022 and 2027.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Oligonucleotide Synthesis Market by Product ((Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom, Predesigned), Reagents, Equipment), Application (Therapeutic (Rare Diseases), Research, Diagnostics) - Global Forecast to 2030
The global oligonucleotide synthesis market, valued at US$8.9 billion in 2024, stood at US$10.5 billion in 2025 and is projected to advance at a resilient CAGR of 18.6% from 2025 to 2030, culminating in a forecasted valuation of US$24.7 billion by the end of the period. The oligonucleotide synthesis market is experiencing significant growth, driven by the increasing applications of synthesized oligonucleotides in therapeutics & diagnostics. This growth is supported by technological advancements and rising investments in life sciences research and synthetic biology.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
